Posted in | News | Nanomaterials

Grafoid Launches Grafprint3D, New Company to Focus on Graphene 3D Printing

Grafoid has announced the worldwide launch of Grafprint3D (GP3D) Inc., a new company with a portfolio of products and solutions to focus on the worldwide additive manufacturing and 3D printing market based on Grafoid’s proprietary MesoGraf™ technology.

Revolutionary Platform for Creation of 3D Printable Materials

Grafprint3D Inc. provides its customers with a revolutionary platform for creation of 3D printable materials that will be utilized to enhance a variety of products and applications for markets including direct ink writing, inkjet printing, screen printing, and more. The initial key application target markets include wearable device fabrication with biocompatible polymers, biomaterial substrates for cell therapy engineering research, and rapid product prototyping with printable advanced nanomaterials.

Entering the 3D Printing Materials Market

“We are extremely excited to launch Grafprint3D Inc. and to be entering the additive manufacturing & consumer 3D printing materials market. We believe our proprietary portfolio of MesoGraf ™-based products will be well received by our customer base,” commented Gary Economo, CEO of Grafoid. “Grafoid and Grafprint3D will continue to collaborate and evolve our product offerings to meet and exceed the expectations of our customers, as we seek to grow and diversify our revenue base.”

The global 3D-printed composite materials market is expected to achieve a CAGR of approximately 38% during the time period 2019-2023, led by the consumer electronics, medical and aerospace and automotive sectors, according to a recent report by Technavio.

Source: http://www.grafoid.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.